Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STAR COMBO PHARMA LIMITED Capital/Financing Update 2020

Feb 27, 2020

65746_rns_2020-02-27_f843d08d-5c85-47cd-864d-a0eb554fd8bd.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Market Announcement

==> picture [33 x 50] intentionally omitted <==

28 February 2020

==> picture [451 x 5] intentionally omitted <==

Star Combo Pharma Limited (ASX: S66) – Trading Halt

Description

The securities of Star Combo Pharma Limited (‘S66’) will be placed in trading halt at the request of S66, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Tuesday, 3 March 2020 or when the announcement is released to the market.

Issued by

Corey Lian

Adviser, Listings Compliance (Sydney)

Market Announcement 1/1 ASX Customer Service Centre 131 279 | asx.com.au

28 February 2020 ASX Limited

==> picture [117 x 53] intentionally omitted <==

STAR COMBO PHARMA LTD ABN 38 6157 283 75 171 -177 Woodpark Rd Smithfield NSW 2164 P: +61 2 9756 6555 [email protected]

28 February 2020

By email : [email protected] [email protected]

Attention : Corey Lian

Australian Securities Exchange Exchange Centre 20 Bridge Street SYDNEY NSW 2000

REQUEST FOR TRADING HALT

Star Combo Pharma Limited (ASX: S66) ( Company ) requests an immediate halt to the trading of the Company's quoted securities on the Australian Securities Exchange ( ASX ) in accordance with ASX Listing Rule 17.1.

The trading halt is requested pending the release of an announcement in relation to a material Share Subscription.

In accordance with Listing Rule 17.1, the Company advises:

  1. The trading halt is necessary to assist the Company in managing its continuous disclosure obligations pending the release of an announcement regarding a material share subscription.

  2. The Company requests that the trading halt remains in place until the earlier of an ASX announcement issued by the Company regarding the transaction, or the commencement of normal trading on Tuesday 3 March 2020.

  3. The Company is not aware of any reason why the trading halt should not be granted or of any further information necessary to inform the market about the trading halt.

Yours faithfully

==> picture [118 x 79] intentionally omitted <==

Patrick Raper Company Secretary Star Combo Pharma Limited

Page 1

ME_161849230_1